Latest News from C4 Imaging
June 9, 2022
Join me by following C4 Imaging here on LinkedIn – and let’s build a community of champions for innovation on a mission for better patient care.
June 9, 2022
A round table featuring Dr. Peter Orio, Dr. Shalin Shah and our founder, Dr. Steven Frank.
June 9, 2022
MRI Assisted Radiosurgery (MARS) Utilizing C4 Imaging’sSirius ® Positive-Signal MRI Markers.
May 31, 2022
C4 Imaging Announces First Prostate Cancer Treatments Utilizing Nova™ Fiducial Markers.
May 31, 2022
C4 Imaging Announces Addition to Board of Directors.
February 16, 2022
C4 Imaging Announces First Cancer Treatment Utilizing Orion HDR MRI Markers In New Mexico.
February 11, 2021
C4 Imaging Announces Successful Completion of an Institutional Financing Round.
January 5, 2021
C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Cesium-131 Brachytherapy Seeds
October 26, 2020
C4 Imaging Announces FDA 510(k) Clearance of its Non-metallic, Multimodality C4 Fiducial Marker
September 11, 2019
C4 Imaging Announces First Prostate Cancer Treatment Utilizing Orion™ HDR MRI Markers
September 12, 2018
Theragenics to Provide Sales and Marketing for C4 Imaging’s New Orion™ HDR MRI Markers
May 8, 2018
C4 Imaging Announces FDA 510(k) Clearance of its Positive-Signal High Dose Rate (HDR) Brachytherapy MRI Treatment Planning Marker
September 5, 2017
C4 Imaging Announces an Additional FDA 510(k) Clearance for its Positive-Signal MRI Marker – Sirius™
August 7, 2017
MRI Assisted Radiosurgery (MARS) Utilizing C4 Imaging’s Sirius™ Positive-Signal MRI Marker is a Cost-Effective Option for the Treatment of Prostate Cancer
December 22, 2016
C4 Imaging to Present at the Medtech Showcase 2017 (PDF)
July 5, 2016
Clinical Study Discusses the Value of C4 Imaging’s Sirius™ Positive-Signal MRI Marker in MRI-Guided Prostate Cancer Treatment (PDF)
Jun 6, 2016
C4 Imaging receives top honors at the 5th annual Texas Life Science Forum (PDF)
September 22, 2015
C4 Imaging Utilizes Evonik’s VESTAKEEP® PEEK For Prostate Cancer Device (PDF)
August 21, 2015
C4 Imaging Awarded $1.3 Million NIH SBIR Phase II Grant (PDF)
April 7, 2014
C4 Imaging Announces First SIRIUS™ Positive Signal MRI Marker Implant (PDF)
March 31, 2014
C4 Imaging Signs SIRIUS™ MRI MARKER Loading Services Agreement with AnazaoHealth Corporation (PDF)
Dec 6, 2013
C4 Imaging Announces FDA 510(k) Clearance of its Positive-Signal MRI Marker – Sirius™ (PDF)